{"id":35186,"date":"2025-06-04T11:52:00","date_gmt":"2025-06-04T09:52:00","guid":{"rendered":"https:\/\/sma.selfempowered.net\/?p=35186"},"modified":"2026-03-16T21:04:50","modified_gmt":"2026-03-16T20:04:50","slug":"evrysdi-in-tablettenform-in-der-eu-zugelassen","status":"publish","type":"post","link":"https:\/\/smartunity.space\/stories\/thema\/evrysdi-in-tablettenform-in-der-eu-zugelassen\/","title":{"rendered":"Evrysdi\u00ae in Tablettenform in der EU zugelassen."},"content":{"rendered":"\n<p>Wie in einem heute am 04. Juni 2025 erschienen Mediarelease von Roche informiert, hat die EMA (Europ\u00e4ische Arzneimittelkommission) die Erweiterung von Evrysdi\u00ae in Form einer Tablette mit 5mg Wirkstoff(Risdiplam) am 02.06.2025 zugelassen. Die 5mg entsprechen der bisherigen H\u00f6chstdosis, von 6,6ml in Fl\u00fcssigform. <em><sub><sup>(mit einer minimalsten Toleranz nach oben &#8220;0,75mg\/ml x6,6 = 4,95mg&#8221; )<\/sup><\/sub><\/em><\/p>\n\n\n\n<p>Die Tablette kann mit oder ohne Nahrung, sowie als ganzes oder auch wieder in Fl\u00fcssigkeit aufgel\u00f6\u00dft geschluckt werden. Eine K\u00fchlung ist nicht mehr notwendig, die Lagerung kann bei Raumtemperatur erfolgen.<\/p>\n\n\n\n<p>Quelle: <a href=\"https:\/\/www.roche.com\/media\/releases\/med-cor-2025-06-04\">Roche Mediarelease 2025-06-04<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wie in einem heute am 04. Juni 2025 erschienen Mediarelease von Roche informiert, hat die EMA (Europ\u00e4ische Arzneimittelkommission) die Erweiterung von Evrysdi\u00ae in Form einer Tablette mit 5mg Wirkstoff(Risdiplam) am 02.06.2025 zugelassen. Die 5mg entsprechen der bisherigen H\u00f6chstdosis, von 6,6ml in Fl\u00fcssigform. (mit einer minimalsten Toleranz nach oben &#8220;0,75mg\/ml x6,6 = 4,95mg&#8221; ) Die Tablette [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6796,"comment_status":"open","ping_status":"closed","sticky":false,"template":"only-view","format":"standard","meta":{"activitypub_content_warning":"","activitypub_content_visibility":"local","activitypub_max_image_attachments":0,"activitypub_interaction_policy_quote":"anyone","activitypub_status":"","footnotes":""},"categories":[1],"tags":[58],"class_list":["post-35186","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-thema","tag-smanews"],"_links":{"self":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/35186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/comments?post=35186"}],"version-history":[{"count":3,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/35186\/revisions"}],"predecessor-version":[{"id":39918,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/35186\/revisions\/39918"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/media\/6796"}],"wp:attachment":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/media?parent=35186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/categories?post=35186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/tags?post=35186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}